Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization

Overview of attention for article published in Pharmaceutics, August 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 4,096 followers.

#Inhalable therapy is a promising treatment approach that may help improve patient adherence to treatment. Check the latest progress on their use in： https://t.co/HeHg91GaVF https://t.co/9WKQCsHODY https://t.co/Z3TNSkhXSu https://t.co/qSkjpTRihG https:/…

#MDPIPharmaceutics 📗 "Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization" by Mohammad A. M. Momin et al. Full paper at https…

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization https://t.co/Ewn65H6pYp #mdpipharmaceutics via @MDPIpharma

Choice of device is as important as formulation endeavors for pulmonary drug delivery with powders. Happy to have contributed. #mdpipharmaceutics #Aerosolization https://t.co/FdmTWyEOO7

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.